Research shows that rapid antigen tests are performing as well at detecting the most recent dominant variants as they did with the earliest strains in the COVID-19 pandemic.
Academic rigor, journalistic flair
Articles on PCR testing for COVID
Displaying all articles
Rapid tests can be an incredibly useful tool for early detection of COVID-19. Unfortunately, they sometimes leave people with more questions than answers.
Here’s what we know from the limited data publicly available.
A nationwide genomic surveillance system analyzes positive COVID-19 tests to build a picture of which variants are spreading in the population.
Knowing when and how often to use rapid tests is key to getting an accurate picture of your COVID-19 status.
Making rapid antigen tests for COVID-19 cheaper and more accessible can catch the infectious cases before they spread and help everyone resume normal activities safely.
With a bit of preparation, role play and modelling the type of behaviour you’d like to see in your child, the process can be plain sailing.
Who’s a good doggie? Sniffer dogs might one day be able to screen people for COVID-19 in large crowds. But not when they’re hungry or need a good lie down.
Even if you’re vaccinated, you still need to come forward for COVID testing, even if you have the mildest symptoms.
A man in the Northern Territory recently received a “weak positive” test result for COVID-19. Understanding how coronavirus tests work shows us why this can happen from time to time.
The CDC has long been a trusted source of health information, keeping the public not only safe but calm in times of disease outbreaks. Public health officials fear now for its reputation.
Top contributors
-
Associate Professor of Molecular Medicine, UMass Chan Medical School
-
Assistant Professor of Medicine, UMass Chan Medical School
-
Associate Professor of Public Policy, University of Maryland, Baltimore County
-
Assistant Professor of Infectious Diseases, University of Pittsburgh
-
Professor of Epidemiology, Medicine, and Infectious Diseases and Microbiology, University of Pittsburgh
-
Associate Professor and Epidemiologist, Infectious Diseases, Immunisation and Emergencies Group, Sydney School of Public Health, University of Sydney
-
Associate Professor of Management, Policy, and Community Health and Epidemiology, University of Texas Health Science Center at Houston
-
PhD candidate, Edith Cowan University
-
Epidemiologist, WHO Collaborating Centre for Reference and Research on Influenza
-
Associate Professor, Epidemiology, Deakin University
-
Senior Research Officer, National Centre for Immunisation Research and Surveillance; PhD candidate, Australian National University
-
Assistant Professor of Pediatrics, Emory University
-
Associate Professor, Edith Cowan University
-
Associate Director of Global Health Research and Innovation Professor of Medicine, Johns Hopkins University
-
Epidemiologist, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
